CLINICAL_TRIALS ClinicalTrials.gov record update

Safety and Efficacy of Brodalumab in the Treatment of Immune-Related Adverse Events: A Pilot Study

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT06673329
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:27:48.335841+00:00
Published At: 2025-05-14T00:00:00+00:00
Record Updated At: 2025-05-14
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Breast Cancer", "Esophageal Cancer", "Kidney Cancer", "Lung Cancer", "Thyroid Cancer", "Gynecologic Cancer", "Pancreatic Cancer", "Stomach Cancer", "Brain Tumor", "Colon Cancer", "Rectal Cancer", "Head and Neck Cancer", "Oral Cancer", "Liver Cancer", "Skin Cancer", "Prostate Cancer", "Testicular Cancer", "Solid Tumor"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2025-05-14"
protocolSection.identificationModule.nctId: "NCT06673329"
protocolSection.identificationModule.officialTitle: "Safety and Efficacy of Brodalumab in the Treatment of Immune-Related Adverse Events: A Pilot Study"
protocolSection.statusModule.overallStatus: "RECRUITING"
protocolSection.designModule.phases: ["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.